share

(Cys39)-Tissue Factor (33-53) CAS NO 313642-01-2


Unit Price:

CAS No.:313642-01-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(Cys39)-Tissue Factor (33-53) CAS NO 313642-01-2 is a synthetic peptide fragment corresponding to a specific region of human Tissue Factor, a key initiator of the blood coagulation cascade. This high-purity peptide is critical for advanced biochemical research and diagnostic development, particularly in the study of thrombosis, hemostasis, and related signaling pathways. It is primarily utilized by research institutions, pharmaceutical R&D departments, and in vitro diagnostic (IVD) manufacturers requiring precise molecular tools for assay development and mechanistic studies.

Application

  • Biochemical Research: Used as a specific antigen or binding partner in studies investigating the structure, function, and inhibition mechanisms of the Tissue Factor pathway.
  • Diagnostic Assay Development: Serves as a critical component in the development and calibration of immunoassays (e.g., ELISA) for detecting Tissue Factor or related biomarkers.
  • Antibody Production & Characterization: Employed for immunizing animals to generate specific antibodies or for screening hybridomas to identify monoclonal antibodies against Tissue Factor.
  • Pharmaceutical Screening: Used in high-throughput screening (HTS) platforms to identify and validate novel therapeutic compounds that modulate Tissue Factor activity.
  • Quality Control Reference: Acts as a reference standard in the quality control of therapeutic biologics or diagnostic kits targeting the coagulation system.
  • Cell Signaling Studies: Applied in cell-based assays to study the downstream effects of Tissue Factor signaling in vascular biology and oncology research.

Basic Information

Product Name (Cys39)-Tissue Factor (33-53)
CAS No. 313642-01-2
Molecular Formula C96H155N29O28S2
Molecular Weight 2187.6 g/mol
Synonyms Tissue Factor (33-53) (Cys39) peptide; TF (33-53) Cys39; Human Tissue Factor residues 33-53 (Cys39); Coagulation Factor III (33-53) fragment; Thromboplastin (33-53) peptide; F3 (33-53) peptide; CD142 (33-53) fragment; H-Tyr-Lys-Asn-Leu-Glu-Glu-Cys-Pro-Lys-Glu-Asp-Glu-Glu-Leu-Phe-Lys-Gln-Asp-Lys-Val-Asn-NH2 (Disulfide bridge: Cys7-Cys39)
EINECS Contact for details

Quality Control

Our (Cys39)-Tissue Factor (33-53) is manufactured under stringent conditions to ensure batch-to-batch consistency and high biological activity. Each lot undergoes comprehensive analytical testing, including HPLC for purity verification, mass spectrometry (MS) for identity confirmation, and amino acid analysis (AAA). A detailed Certificate of Analysis (COA) documenting purity, peptide content, and solvent residues is provided with every shipment to support your quality and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. For long-term storage, keep the lyophilized powder at -20°C or below. Once reconstituted, aliquot the solution to avoid repeated freeze-thaw cycles and store at -80°C. The product is hygroscopic (moisture-sensitive); ensure the vial is equilibrated to room temperature before opening to prevent moisture condensation.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (HPLC & MS) Conforms to reference standard
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80% (by AAA)
Molecular Weight 2187.6 ± 2.0 Da (by MS)
Solvent Residues Meets ICH guidelines
Water Content (K.F.) ≤ 5.0%
Biological Activity Assay-dependent; data available on COA

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.